Axsome Therapeutics Inc

1AXSM

Company Profile

  • Business description

    Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

  • Contact

    One World Trade Center
    22nd Floor
    New YorkNY10007
    USA

    T: +1 212 332-3241

    E: [email protected]

    https://www.axsome.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    589

Stocks News & Analysis

stocks

Ask the analyst: Are markets missing something with CSL?

I catch up with Shane Ponraj after an eventful reporting season for healthcare major CSL.
stocks

This ASX stock’s bubble has well and truly burst

Pandemic related tailwinds are a distant memory for Reece, which looks set to face more competition in Australia.
stocks

Tesla’s stock is in trouble, but this fund manager sees a comeback in 2026

Tesla’s challenges echo past issues the company has overcome, says Zevenbergen’s Joe Dennison.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,231.102.600.03%
CAC 407,743.9334.120.44%
DAX 4024,046.21106.66-0.44%
Dow JONES (US)45,565.23147.160.32%
FTSE 1009,255.5010.30-0.11%
HKSE25,201.76323.16-1.27%
NASDAQ21,590.1445.870.21%
Nikkei 22542,520.27125.870.30%
NZX 50 Index12,861.8496.14-0.74%
S&P 5006,481.4015.460.24%
S&P/ASX 2008,960.500.70-0.01%
SSE Composite Index3,800.3568.03-1.76%

Market Movers